Use of the EUDAMED Actor module is expected to be published in the Official Journal of the EU (OJEU) in Q1-Q3 2025. Afterward, a 12-month transition period will apply for the medical devices and a 6-month transition period will apply for IVDs. 

After the transition periods end, all manufacturers, system/procedure pack producers, importers, and authorized representatives must be registered in EUDAMED. Further, all CE Marked medical devices and IVDs, including legacy devices, must be registered in EUDAMED.

The exact compliance date will depend on the day the notice is published in the OJEU.

More information can be found: HERE